Arch. Endocrinol. Metab. 2020;64(3):199-200
Type 2 diabetes as a major risk factor for COVID-19 severity: a meta-analysis
DOI: 10.20945/2359-3997000000256
DEAR EDITOR,
Coronavirus disease 2019 (COVID-19) has recently emerged as a rapidly spreading disease, affecting more than 100 countries worldwide and reaching pandemic proportions. The severity of COVID-19 ranges from a mild, self-limiting flu-like illness to a devastating pneumonia culminating in respiratory failure and death. Individuals with diabetes are particularly vulnerable to some respiratory viral infections, such as influenza A (H1N1) infection ( ), the severe acute respiratory syndrome (SARS) ( ), and the Middle East respiratory syndrome (MERS) ( ). A higher mortality rate was recently suggested in patients with COVID-19 who had preexisting diabetes ( ); according to the Chinese Centers for Disease Control and Prevention, COVID-19 case-fatality rates in patients with diabetes were around 7.3%, versus 2.3% in the general Chinese population.
[…]
